ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Cancer Institute Hospital of JFCR at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Cancer Institute Hospital of JFCR takes part in 8 sessions at ESMO 2026 in Madrid. Its work spans molecular profiling and treatment across kidney, breast, gastric, lung and ovarian cancers. It examines whether blood-based tumour DNA monitoring can help track relapse after breast cancer surgery.
| Organization | ESMO 2026 Attendance |
|---|---|
Cancer Institute Hospital of JFCR Tokyo, Japan | |
Specialist cancer hospital in the Ariake district of Tokyo, Japan, run by the nonprofit Japanese Foundation for Cancer Research. | Poster Fri Oct 23 15:15–16:00 Abstract Fri Oct 23 16:42–16:47 Poster Sat Oct 24 12:00–12:45 ICI-associated CRS/HLH-like syndrome: Clinical characteristics and biomarker-based diagnostic framework Biomarkers & precision oncology Talk Sun Oct 25 10:55–11:15 Novel ADC therapies Genitourinary cancers Poster Sun Oct 25 12:00–12:45 Distinct clinicopathological and molecular features of dual HER2/CLDN18.2-positive gastric cancer Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Molecular profiling and clinical outcomes in Japanese patients with small bowel adenocarcinoma: A nationwide real-world study Gastrointestinal cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Cancer Institute Hospital of JFCR
Tell us what you sell and we’ll find the people at Cancer Institute Hospital of JFCR most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction